LCM
FLACU

Laurion Capital Management’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Laurion Capital Management’s Portfolio FLACU Stock Details FLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50,000
Closed -$511K – 1032
2021
Q1 		$511K Hold
50,000
– – ﹤0.01% 586
2020
Q4 		$521K Buy
+50,000
New +$522K ﹤0.01% 480

Other funds holding FLACU

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Laurion Capital Management's FLACU Position: Q2 2021 in Review

Laurion Capital Management sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q2 2021, closing a stake of 50,000 shares — an estimated $511K sold.

Laurion Capital Management first reported a position in FLACU in Q4 2020 and held it in 2 quarters. The position peaked at $521K in Q4 2020. 32 funds tracked by Wall St. Rank hold FLACU as of Q2 2021.

  • Laurion Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q2 2021 after selling out during the quarter.
  • Laurion Capital Management sold 50,000 Frazier Lifesciences Acquisition Corporation Unit shares in Q2 2021, an estimated $511K.
  • Laurion Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 2 quarters.
  • Laurion Capital Management's Frazier Lifesciences Acquisition Corporation Unit position peaked at $521K in Q4 2020.
  • 32 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q2 2021.

Based on Laurion Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.